Miramar Labs said it landed a $10 million Series D round it plans to use to boost sales of its miraDry system.
Sunnyvale, Calif.-based Miramar makes dermatology devices including its flagship miraDry system, a laser-based treatment for excessive underarm sweat. The device, which uses microwave energy to eliminate sweat glands, recently won CE Mark approval in the European Union.
Previous investors Aisling Capital, Cross Creek Capital, Domain Associates and Morgenthaler Ventures all participated in the round. New backer RusnanoMedInvest also participated, according to a press release.
“We have been very pleased with our growth in 2013 as awareness of the miraDry Procedure increased significantly here in the U.S. and internationally. Not only will this new round of funding enable us to expand our commercialization and global sales efforts, providing the only non-invasive and lasting treatment option for unwanted underarm sweat, but it will also allow us to accelerate the development and introduction of important new technology platforms in the near future,” president & CEO R. Michael Kleine said in prepared remarks.